TAKE ACTION! - - - OPPOSE House Resolution 327
(Note: This is a resolution, not a bill and cannot become law, but the resolution claims that there is a consensus on vaccine safety. This is not true.)
Please CONTACT your Congressional Representative.
“I ask Congressperson ______ to oppose this resolution.
>> Vaccines do have risks, as evidenced in manufacturer warnings, compensation payouts and current science. Consider the facts:
1. In 2011, the U.S. Supreme Court said that vaccines are unavoidably unsafe. Vaccine manufacturers have no liability for the harm cause by their vaccines, and thus no incentive to make safer vaccines.
2. Vaccine manufacturers (drug companies) provide consumer product warnings inside “package inserts” for each vaccine. In the US, the FDA regulates the contents of these labels that accompany the product to the doctor or health department office. From these FDA regulated package inserts, one can plainly see that there is evidence of severe, life threatening side effects or, in some cases the risks have not been evaluated, for every vaccine approved by the CDC.
3. Federal government payouts for vaccine injury and death as of June 2017 total $3.7 Billion.
Where there is risk, there must be choice. Congress should be protecting consumers in this regard. Oppose HR327. Thank you.
VERMONT: Peter Welch
2303 Rayburn House Office Building
Washington, DC 20515
Phone: (202) 225-4115
128 Lakeside Ave- Suite 235
Burlington, VT 05401
Phone: (802) 652-2450
 Bruesewitz v. Wyeth LLC https://www.supremecourt.gov/opinions/10pdf/09-152.pdf
 National Childhood Vaccine Injury Act of 1986, 42 U.S.C. § 300aa-1 et seq., and Bruesewitz, supra http://www.uscfc.uscourts.gov/vaccine-program-readmore
 US Food and Drug Administration, Vaccines Licensed for Use in the United States https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm093833.htm?mc_cid=507bfbc377&mc_eid=d9ddda5b75
 National Vaccine Injury Compensation Program (NVICP) Statistics Report, June 2, 2017 https://www.hrsa.gov/sites/default/files/vaccinecompensation/data/vicpmonthlyreporttemplate5_1_17.pdf